TrialBlood2010

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

Larry D Cripe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.